Skip to main content
Journal cover image

Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA Trial.

Publication ,  Journal Article
Gill, BC; Thomas, S; Barden, L; Jelovsek, JE; Meyer, I; Chermansky, C; Komesu, YM; Menefee, S; Myers, D; Smith, A; Mazloomdoost, D; Amundsen, CL
Published in: J Urol
August 2023

PURPOSE: We determined the utility of intraoperative data in predicting sacral neuromodulation outcomes in urgency urinary incontinence. MATERIALS AND METHODS: Intraoperative details of sacral neuromodulation stage 1 were recorded during the prospective, randomized, multicenter ROSETTA trial, including responsive electrodes, amplitudes, and response strengths (motor and sensory Likert scales). Stage 2 implant was performed for stage 1 success on 3-day diary with 24-month follow-up. An intraoperative amplitude response score for each electrode was calculated ranging from 0 (no response) to 99.5 (maximum response, 0.5 V). Predictors for stage 1 success and improvement at 24 months were identified by stepwise logistic regression confirmed with least absolute shrinkage and selection operator and stepwise linear regression. RESULTS: Intraoperative data from 161 women showed 139 (86%) had stage 1 success, which was not associated with number of electrodes generating an intraoperative motor and/or sensory response, average amplitude at responsive electrodes, or minimum amplitude-producing responses. However, relative to other electrodes, a best amplitude response score for bellows at electrode 3 was associated with stage 1 failure, a lower reduction in daily urgency urinary incontinence episodes during stage 1, and most strongly predicted stage 1 outcome in logistic modeling. At 24 months, those who had electrode 3 intraoperative sensory response had lower mean reduction in daily urgency urinary incontinence episodes than those who had no response. CONCLUSIONS: Specific parameters routinely assessed intraoperatively during stage 1 sacral neuromodulation for urgency urinary incontinence show limited utility in predicting both acute and long-term outcomes. However, lead position as it relates to the trajectory of the sacral nerve root appears to be important.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Urol

DOI

EISSN

1527-3792

Publication Date

August 2023

Volume

210

Issue

2

Start / End Page

331 / 340

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Urinary Incontinence, Urge
  • Urinary Incontinence
  • Urinary Bladder, Overactive
  • Treatment Outcome
  • Transcutaneous Electric Nerve Stimulation
  • Sacrum
  • Prospective Studies
  • Lumbosacral Plexus
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gill, B. C., Thomas, S., Barden, L., Jelovsek, J. E., Meyer, I., Chermansky, C., … Amundsen, C. L. (2023). Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA Trial. J Urol, 210(2), 331–340. https://doi.org/10.1097/JU.0000000000003498
Gill, Bradley C., Sonia Thomas, Lindsey Barden, J Eric Jelovsek, Isuzu Meyer, Christopher Chermansky, Yuko M. Komesu, et al. “Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA Trial.J Urol 210, no. 2 (August 2023): 331–40. https://doi.org/10.1097/JU.0000000000003498.
Gill BC, Thomas S, Barden L, Jelovsek JE, Meyer I, Chermansky C, et al. Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA Trial. J Urol. 2023 Aug;210(2):331–40.
Gill, Bradley C., et al. “Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA Trial.J Urol, vol. 210, no. 2, Aug. 2023, pp. 331–40. Pubmed, doi:10.1097/JU.0000000000003498.
Gill BC, Thomas S, Barden L, Jelovsek JE, Meyer I, Chermansky C, Komesu YM, Menefee S, Myers D, Smith A, Mazloomdoost D, Amundsen CL. Intraoperative Predictors of Sacral Neuromodulation Implantation and Treatment Response: Results From the ROSETTA Trial. J Urol. 2023 Aug;210(2):331–340.
Journal cover image

Published In

J Urol

DOI

EISSN

1527-3792

Publication Date

August 2023

Volume

210

Issue

2

Start / End Page

331 / 340

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Urinary Incontinence, Urge
  • Urinary Incontinence
  • Urinary Bladder, Overactive
  • Treatment Outcome
  • Transcutaneous Electric Nerve Stimulation
  • Sacrum
  • Prospective Studies
  • Lumbosacral Plexus
  • Humans